Johnson & Johnson MedTech Completes Pilot Phase Enrollment of OMNY-AF Trial Evaluating Large-Tip, Focal Pulsed Field Ablation Omnypulse Catheter
October 31, 2024
October 31, 2024
NEW BRUNSWICK, New Jersey, Oct. 31 (TNSres) -- Johnson and Johnson issued the following news release:
* * *
The OMNY-AF trial evaluates safety and efficacy of the investigational OMNYPULSE Platform, a novel catheter that combines a large ablation area with mapping capabilities
* * *
Irvine, CA - October 30, 2024 - Today, Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, announced the enrollment completion of the pi . . .
* * *
The OMNY-AF trial evaluates safety and efficacy of the investigational OMNYPULSE Platform, a novel catheter that combines a large ablation area with mapping capabilities
* * *
Irvine, CA - October 30, 2024 - Today, Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, announced the enrollment completion of the pi . . .